Rituxy 100 Mg Injection

उत्पाद वर्णन

Product introduction

Rituxem 100mg Injection is used in the treatment of non-Hodgkin lymphoma (NHL), rheumatoid arthritis, blood cancer (chronic lymphocytic leukemia), granulomatosis with polyangiitis and microscopic polyangiitis.

Rituxem 100mg Injection is given as an injection under the supervision of doctor. You must take it in a dose as advised by the doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.

The most common side effects of this medicine include headache, weakness, edema, infection, and hair loss. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with hepatitis B.

How Rituxy 100 Mg Injection Works

Rituxy 100 Mg Injection operates by targeting and attaching to CD20 proteins found on the surface of abnormal B-cells. This action facilitates the destruction of these cells, making it effective against certain cancers and autoimmune disorders. Due to its targeted mechanism, Rituxy provides a specialized approach that may result in fewer side effects compared to traditional therapies.


Proper Storage and Handling

Rituxy should be stored in a refrigerator at temperatures between 2C and 8C. It is crucial not to freeze the medication and to keep it protected from light. Proper storage ensures the stability and efficacy of the drug, preserving its therapeutic benefits until the expiry date, which is 24 months from the manufacturing date.


Administration and Dosage Guidelines

This injection is designed for intravenous administration and must be given by healthcare professionals. The dosage and treatment schedule are carefully determined by the prescribing physician based on the individual's condition and response to previous treatments. Patients should not self-administer and should always follow the physician's instructions.